A few key points:
- The FDA study does indeed replicate the positive results of the original XMRV study, showing XMRV in the blood of CFS patients.
- Andrea Whittemore, daughter of the founders of the Whittemore-Peterson Institute, is already "significantly improved" on treatments for XMRV.
- Another paper due out at the end of the year will show that XMRV causes immune system abnormalities.
- Several drugs have already been shown to be effective against XMRV in the laboratory.
- Pharmaceutical companies that halted their work based on earlier negative studies have resumed work on medications to treat XMRV, including many that are already on the market.
- Treatment trials with real patients should begin soon at WPI.
hi Sue that really is good news maybe with extra funding an effective drug may just be around the corner. If you visit on the attatched link http://dld.bz/mBZq and like what we are trying to achieve, you might consider exchanging your HTML banner code or your URL so we can advertise on each others sites and hopefully spread the word to a greater audience.
ReplyDeleteJulie x
Ohh, what good news, Sue! Thank you for posting! It's interesting that regarding CFS and Lyme one may be a virus and the other is a bacteria. Yet the symptoms are the same. So for people with both diseases... how curious.
ReplyDeleteJudy